Tissue-Tek Cryomold Intermediate 15x15x5
To Order Contact us: lieven@wlsolutions.be
TAM558 intermediate-1 |
||
| HY-400687 | Get quote | Ask for price |
|
Description: TAM558 intermediate-1 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity[1]. |
||
TAM558 intermediate-2 |
||
| HY-400688 | Get quote | Ask for price |
|
Description: TAM558 intermediate-24 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity[1]. |
||
TAM558 intermediate-3 |
||
| HY-400689 | Get quote | Ask for price |
|
Description: TAM558 intermediate-34 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity[1]. |
||
TAM558 intermediate-4 |
||
| HY-400690 | Get quote | Ask for price |
|
Description: TAM558 intermediate-4 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity[1]. |
||
TAM558 intermediate-5 |
||
| HY-48564 | 1 mg | EUR 3517.37 |
|
Description: TAM558 intermediate-54 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity[1]. |
||
Moramide Intermediate |
||
| M303090 | 100mg | EUR 242 |
Methadone Intermediate |
||
| D297255 | 100mg | EUR 172 |
|
Description: 125-79-1 |
||
Docetaxel intermediate |
||
| TBZ2829 | 20mg | Ask for price |
Tesirine intermediate-2 |
||
| HY-24144 | 1 mg | EUR 3852.87 |
|
Description: Tesirine intermediate-2 is the intermediate of Tesirine (HY-128952). Tesirine (SG3249), a pyrrole benzodiazepine (PBD) dimer, is a DNA small channel crosslinker with strong cytotoxicity. Tesirine can be used to synthesize Antibody-Drug Conjugates (ADCs), the warhead component of the payload is SG3199 (HY-101161), which has strong anticancer cell activity. |
||
Tesirine intermediate-1 |
||
| HY-47820 | 1 mg | EUR 2997.88 |
|
Description: Tesirine intermediate-1 is the intermediate of Tesirine (HY-128952). Tesirine (SG3249), a pyrrole benzodiazepine (PBD) dimer, is a DNA small channel crosslinker with strong cytotoxicity. Tesirine can be used to synthesize Antibody-Drug Conjugates (ADCs), the warhead component of the payload is SG3199 (HY-101161), which has strong anticancer cell activity. |
||
CRAC intermediate 1 |
||
| HY-20587 | 10mM/1mL | EUR 378.79 |
CRAC intermediate 2 |
||
| HY-20588 | 50mg | EUR 324.68 |
MMAF intermediate 1 |
||
| HY-79253 | 100 mg | EUR 86.58 |
|
Description: MMAF intermediate 1 is an intermediate in the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A[1]. |
||
MMAF intermediate 2 |
||
| HY-79254 | 100 mg | EUR 259.74 |
|
Description: MMAF intermediate 2 is an intermediate for the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A[1]. |
||
CRAC intermediate 2 |
||
| MBS3840030-100mg | 100mg | EUR 590 |
CRAC intermediate 2 |
||
| MBS3840030-10mg | 10mg | EUR 170 |
CRAC intermediate 2 |
||
| MBS3840030-50mg | 50mg | EUR 320 |
CRAC intermediate 2 |
||
| MBS3840030-5mg | 5mg | EUR 135 |
CRAC intermediate 2 |
||
| MBS3840030-5x100mg | 5x100mg | EUR 2650 |
CRAC intermediate 1 |
||
| MBS3845043-100mg | 100mg | EUR 910 |
CRAC intermediate 1 |
||
| MBS3845043-10mg | 10mg | EUR 210 |
CRAC intermediate 1 |
||
| MBS3845043-50mg | 50mg | EUR 485 |
CRAC intermediate 1 |
||
| MBS3845043-5mg | 5mg | EUR 165 |
CRAC intermediate 1 |
||
| MBS3845043-5x100mg | 5x100mg | EUR 4085 |
CRAC intermediate 1 |
||
| MBS5752952-10mg | 10mg | EUR 190 |
CRAC intermediate 1 |
||
| MBS5752952-25mg | 25mg | EUR 255 |
CRAC intermediate 1 |
||
| MBS5752952-2mg | 2mg | EUR 145 |
CRAC intermediate 1 |
||
| MBS5752952-50mg | 50mg | EUR 345 |
CRAC intermediate 1 |
||
| MBS5752952-5mg | 5mg | EUR 160 |
CRAC intermediate 2 |
||
| MBS5752953-100mg | 100mg | EUR 420 |
CRAC intermediate 2 |
||
| MBS5752953-10mg | 10mg | EUR 180 |
CRAC intermediate 2 |
||
| MBS5752953-25mg | 25mg | EUR 240 |
CRAC intermediate 2 |
||
| MBS5752953-50mg | 50mg | EUR 310 |
CRAC intermediate 2 |
||
| MBS5752953-5mg | 5mg | EUR 150 |
CRAC intermediate 1 |
||
| T10884-10mg | 10mg | Ask for price |
|
Description: CRAC intermediate 1 |
||
CRAC intermediate 1 |
||
| T10884-1g | 1g | Ask for price |
|
Description: CRAC intermediate 1 |
||
CRAC intermediate 1 |
||
| T10884-1mg | 1mg | Ask for price |
|
Description: CRAC intermediate 1 |
||
CRAC intermediate 1 |
||
| T10884-50mg | 50mg | Ask for price |
|
Description: CRAC intermediate 1 |
||
CRAC intermediate 1 |
||
| T10884-5mg | 5mg | Ask for price |
|
Description: CRAC intermediate 1 |
||
CRAC intermediate 2 |
||
| T10885-10mg | 10mg | Ask for price |
|
Description: CRAC intermediate 2 |
||
CRAC intermediate 2 |
||
| T10885-1g | 1g | Ask for price |
|
Description: CRAC intermediate 2 |
||
CRAC intermediate 2 |
||
| T10885-1mg | 1mg | Ask for price |
|
Description: CRAC intermediate 2 |
||
CRAC intermediate 2 |
||
| T10885-50mg | 50mg | Ask for price |
|
Description: CRAC intermediate 2 |
||
CRAC intermediate 2 |
||
| T10885-5mg | 5mg | Ask for price |
|
Description: CRAC intermediate 2 |
||
Taltobulin intermediate-10 |
||
| HY-46004 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-10 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-11 |
||
| HY-46005 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-11 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-12 |
||
| HY-46006 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-12 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Cabazitaxel intermediate |
||
| MBS5761998-1mg | 1mg | EUR 310 |
Cabazitaxel intermediate |
||
| MBS5761998-5x1mg | 5x1mg | EUR 1235 |
Cabazitaxel intermediate |
||
| TN3554-10mg | 10mg | Ask for price |
|
Description: Cabazitaxel intermediate |
||
Cabazitaxel intermediate |
||
| TN3554-1g | 1g | Ask for price |
|
Description: Cabazitaxel intermediate |
||
Cabazitaxel intermediate |
||
| TN3554-1mg | 1mg | Ask for price |
|
Description: Cabazitaxel intermediate |
||
Cabazitaxel intermediate |
||
| TN3554-50mg | 50mg | Ask for price |
|
Description: Cabazitaxel intermediate |
||
Cabazitaxel intermediate |
||
| TN3554-5mg | 5mg | Ask for price |
|
Description: Cabazitaxel intermediate |
||
Taltobulin intermediate-2 |
||
| HY-41043 | 10 mg | EUR 125.54 |
|
Description: Taltobulin intermediate-2 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-1 |
||
| HY-41047 | 100 mg | EUR 216.45 |
|
Description: Taltobulin intermediate-1 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-3 |
||
| HY-41054 | 100 mg | EUR 108.23 |
|
Description: Taltobulin intermediate-3 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-4 |
||
| HY-41055 | 100 mg | EUR 427.5 |
|
Description: Taltobulin intermediate-4 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-5 |
||
| HY-41066 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-5 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-6 |
||
| HY-41067 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-6 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-7 |
||
| HY-41069 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-7 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-8 |
||
| HY-41070 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-8 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
Taltobulin intermediate-9 |
||
| HY-41071 | Get quote | Ask for price |
|
Description: Taltobulin intermediate-9 is an intermediate in the synthesis of Taltobulin (HY-15584). Taltobulin is a common toxin component in ADC preparation (ADC Cytotoxin), and it is also a powerful tubulin (Microtubule/Tubulin) inhibitor. Taltobulin disrupts tubulin polymerization, induces mitotic arrest, and induces apoptosis[1]. |
||
LX-4211 intermediate |
||
| MBS5759515-100mg | 100mg | EUR 320 |
LX-4211 intermediate |
||
| MBS5759515-10mg | 10mg | EUR 160 |
LX-4211 intermediate |
||
| MBS5759515-25mg | 25mg | EUR 200 |
LX-4211 intermediate |
||
| MBS5759515-50mg | 50mg | EUR 250 |
LX-4211 intermediate |
||
| MBS5759515-5mg | 5mg | EUR 145 |
LX-2761 intermediate |
||
| MBS5759518-100mg | 100mg | EUR 320 |
LX-2761 intermediate |
||
| MBS5759518-10mg | 10mg | EUR 160 |
LX-2761 intermediate |
||
| MBS5759518-25mg | 25mg | EUR 200 |
LX-2761 intermediate |
||
| MBS5759518-50mg | 50mg | EUR 250 |
LX-2761 intermediate |
||
| MBS5759518-5mg | 5mg | EUR 145 |
LX-4211 intermediate |
||
| T8750-10mg | 10mg | Ask for price |
|
Description: LX-4211 intermediate |
||
LX-4211 intermediate |
||
| T8750-1g | 1g | Ask for price |
|
Description: LX-4211 intermediate |
||
LX-4211 intermediate |
||
| T8750-1mg | 1mg | Ask for price |
|
Description: LX-4211 intermediate |
||
LX-4211 intermediate |
||
| T8750-50mg | 50mg | Ask for price |
|
Description: LX-4211 intermediate |
||
LX-4211 intermediate |
||
| T8750-5mg | 5mg | Ask for price |
|
Description: LX-4211 intermediate |
||
LX-2761 intermediate |
||
| T8753-10mg | 10mg | Ask for price |
|
Description: LX-2761 intermediate |
||
LX-2761 intermediate |
||
| T8753-1g | 1g | Ask for price |
|
Description: LX-2761 intermediate |
||
LX-2761 intermediate |
||
| T8753-1mg | 1mg | Ask for price |
|
Description: LX-2761 intermediate |
||
LX-2761 intermediate |
||
| T8753-50mg | 50mg | Ask for price |
|
Description: LX-2761 intermediate |
||
LX-2761 intermediate |
||
| T8753-5mg | 5mg | Ask for price |
|
Description: LX-2761 intermediate |
||
Fondaparinux intermediate |
||
| GC5562 | 1mg | EUR 2799.38 |
Fondaparinux intermediate |
||
| GC5562-1 | 1 | EUR 615.3 |
Fondaparinux intermediate |
||
| GC5562-10 | 10 | EUR 3057.4 |
Fondaparinux intermediate |
||
| GC5562-2 | 2 | EUR 950.8 |
Fondaparinux intermediate |
||
| GC5562-5 | 5 | EUR 1864.3 |
Alisporivir intermediate-1 |
||
| HY-P1358 | 1mg | EUR 374.4 |
Alisporivir intermediate-1 |
||
| MBS5763873-1mg | 1mg | EUR 245 |
Alisporivir intermediate-1 |
||
| MBS5763873-5mg | 5mg | EUR 580 |
Alisporivir intermediate-1 |
||
| MBS5763873-5x5mg | 5x5mg | EUR 2470 |
Alisporivir intermediate-1 |
||
| TP1874-10mg | 10mg | Ask for price |
|
Description: Alisporivir intermediate-1 |
||
Alisporivir intermediate-1 |
||
| TP1874-1g | 1g | Ask for price |
|
Description: Alisporivir intermediate-1 |
||
Alisporivir intermediate-1 |
||
| TP1874-1mg | 1mg | Ask for price |
|
Description: Alisporivir intermediate-1 |
||
Alisporivir intermediate-1 |
||
| TP1874-50mg | 50mg | Ask for price |
|
Description: Alisporivir intermediate-1 |
||
Alisporivir intermediate-1 |
||
| TP1874-5mg | 5mg | Ask for price |
|
Description: Alisporivir intermediate-1 |
||
BWA-522 intermediate-2 |
||
| HY-400766 | 10 mg | EUR 140.69 |
|
Description: BWA-522 intermediate-2 is a BWA-522 intermediate. BWA-522 is an orally available small molecule protein-targeting chimera (PROTACs) with significant degradation effect on AR-FL and AR-V7[1]. |
||
BWA-522 intermediate-3 |
||
| HY-401056 | Get quote | Ask for price |
|
Description: BWA-522 intermediate-3 is a BWA-522 intermediate. BWA-522 is an orally available small molecule protein-targeting chimera (PROTACs) with significant degradation effect on AR-FL and AR-V7[1]. |
||
KTX-582 intermediate-2 |
||
| HY-49432 | 10 mg | EUR 324.68 |
|
Description: KTX-582 intermediate-2 is an intermediate in the synthesis of KTX-582 (HY-148274) and can be used for ADC preparation. KTX-582 is an IRAK4 degrader and inducer of apoptosis with DC50 of 4 nM and 5 nM for IRAK4 and Ikaros, respectively[1]. |
||
KTX-582 intermediate-3 |
||
| HY-49435 | Get quote | Ask for price |
|
Description: KTX-582 intermediate-3 is an intermediate in the synthesis of KTX-582 (HY-148274) and can be used for ADC preparation. KTX-582 is an IRAK4 degrader and inducer of apoptosis with DC50 of 4 nM and 5 nM for IRAK4 and Ikaros, respectively[1]. |
||
KTX-582 intermediate-1 |
||
| HY-49436 | 10 mg | EUR 194.81 |
|
Description: KTX-582 intermediate-1 is an intermediate in the synthesis of KTX-582 (HY-148274) and can be used for ADC preparation. KTX-582 is an IRAK4 degrader and inducer of apoptosis with DC50 of 4 nM and 5 nM for IRAK4 and Ikaros, respectively[1]. |
||
Dolutegravir intermediate-1 |
||
| D528812 | 10mg | EUR 305 |
|
Description: 1335210-23-5 |
||
Dolutegravir intermediate-1 |
||
| HY-100083 | 10mg | EUR 75.76 |
|
Description: Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection. |
||
Dolutegravir intermediate-1 |
||
| MBS3844797-10mg | 10mg | EUR 375 |
Dolutegravir intermediate-1 |
||
| MBS3844797-1mg | 1mg | EUR 140 |
Dolutegravir intermediate-1 |
||
| MBS3844797-50mg | 50mg | EUR 1015 |
Dolutegravir intermediate-1 |
||
| MBS3844797-5mg | 5mg | EUR 250 |
Dolutegravir intermediate-1 |
||
| MBS3844797-5x50mg | 5x50mg | EUR 4570 |
Dolutegravir intermediate-1 |
||
| MBS5753036-100mg | 100mg | EUR 550 |
Dolutegravir intermediate-1 |
||
| MBS5753036-10mg | 10mg | EUR 210 |
Dolutegravir intermediate-1 |
||
| MBS5753036-1mg | 1mg | EUR 145 |
Dolutegravir intermediate-1 |
||
| MBS5753036-50mg | 50mg | EUR 390 |
Dolutegravir intermediate-1 |
||
| MBS5753036-5mg | 5mg | EUR 175 |
Dolutegravir intermediate-1 |
||
| T11074-10mg | 10mg | Ask for price |
|
Description: Dolutegravir intermediate-1 |
||
Dolutegravir intermediate-1 |
||
| T11074-1g | 1g | Ask for price |
|
Description: Dolutegravir intermediate-1 |
||
Dolutegravir intermediate-1 |
||
| T11074-1mg | 1mg | Ask for price |
|
Description: Dolutegravir intermediate-1 |
||
Dolutegravir intermediate-1 |
||
| T11074-50mg | 50mg | Ask for price |
|
Description: Dolutegravir intermediate-1 |
||
Dolutegravir intermediate-1 |
||
| T11074-5mg | 5mg | Ask for price |
|
Description: Dolutegravir intermediate-1 |
||
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) |
||
| MBS649598-01mg | 0.1mg | EUR 665 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) |
||
| MBS649598-5x01mg | 5x0.1mg | EUR 2850 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) |
||
| MBS644769-01mg | 0.1mg | EUR 630 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) |
||
| MBS644769-5x01mg | 5x0.1mg | EUR 2680 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) |
||
| MBS642709-005mg | 0.05mg | EUR 630 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) |
||
| MBS642709-5x005mg | 5x0.05mg | EUR 2680 |
SMD-3040 intermediate-1 |
||
| HY-400342 | Get quote | Ask for price |
|
Description: SMD-3040 intermediate-1 is an intermediate of SMD-3040 (HY-156568)[1]. |
||
SMD-3040 intermediate-2 |
||
| HY-400685 | 10 mg | EUR 86.58 |
|
Description: SMD-3040 intermediate-2 is an intermediate in the synthesis of SMD-3040 (HY-156568). SMD-3040 contains SMARCA2/4 ligands, linker and VHL ligands and is a selective SMARCA2 degrader. MD-3040 can be used for ADC drug synthesis and has strong tumor growth inhibition in tumor xenograft models[1]. |
||
Exatecan intermediate 8 |
||
| HY-400316 | Get quote | Ask for price |
|
Description: Exatecan intermediate 8 is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM)[1]. |
||
Exatecan Intermediate 1 |
||
| HY-42487 | 1 g | EUR 91.99 |
|
Description: Exatecan Intermediate 1 (compound 6) is an intermediate of Exatecan (DX-8951, HY-13631). Exatecan is an anticancer agent belonging to the class of camptothecin analogs. Exatecan interferes with the proliferation and division of tumor cells by interacting with DNA, thereby inhibiting tumor growth. Exatecan is primarily used for research of a variety of cancers including ovarian, lung and breast cancers[1][2]. |
||
Exatecan Intermediate 5 |
||
| HY-43564 | 100 mg | EUR 427.5 |
|
Description: Exatecan Intermediate 5 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 5 can be used to synthesize Antibody-Drug Conjugates (ADCs). |
||
Exatecan intermediate 9 |
||
| HY-43565 | Get quote | Ask for price |
|
Description: Exatecan intermediate 9 is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM)[1]. |
||
Exatecan intermediate 10 |
||
| HY-43565B | Get quote | Ask for price |
|
Description: Exatecan intermediate 10 is an intermediate in the synthesis of Exatecan (HY-13631).Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 of 2[1].2 μM (0[1].975 μg/mL) for use in cancer research[1]. |
||
Exatecan Intermediate 6 |
||
| HY-44369 | 1 g | EUR 32.47 |
|
Description: Exatecan Intermediate 6 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 6 can be used to synthesize Antibody-Drug Conjugates (ADCs). |
||
Exatecan Intermediate 7 |
||
| HY-45157 | 100 mg | EUR 346.33 |
|
Description: Exatecan Intermediate 7 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 7 can be used to synthesize Antibody-Drug Conjugates (ADCs). |
||
Exatecan Intermediate 3 |
||
| HY-46081 | Get quote | Ask for price |
|
Description: Exatecan Intermediate 3 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 3 can be used to synthesize Antibody-Drug Conjugates (ADCs). |
||
Exatecan intermediate 11 |
||
| HY-49861 | Get quote | Ask for price |
|
Description: Exatecan intermediate 11 is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM)[1]. |
||
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) |
||
| MBS6010871-02mL | 0.2(mL | EUR 695 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) |
||
| MBS6010871-5x02mL | 5x0.2mL | EUR 2975 |
L2H2-6OTD intermediate-1 |
||
| HY-48517 | 10 mg | EUR 3290.09 |
|
Description: L2H2-6OTD intermediate-1 is an intermediate for the synthesis of L2H2-6OTD (HY-148200) and can be used for ADC preparation. L2H2-6OTD, a telomestatin analog with telomerase inhibitory activity (IC50: 15 nM)[1]. |
||
L2H2-6OTD intermediate-2 |
||
| HY-48625 | 10 mg | EUR 1342.01 |
|
Description: L2H2-6OTD intermediate-2 is an intermediate of telomerase inhibitor, which can be used in the synthesis of ADC[1]. |
||
L2H2-6OTD intermediate-3 |
||
| HY-48626 | Get quote | Ask for price |
|
Description: L2H2-6OTD intermediate-3 is an intermediate for the synthesis of L2H2-6OTD (HY-148200) and can be used for ADC preparation. L2H2-6OTD, a telomestatin analog with telomerase inhibitory activity (IC50: 15 nM)[1]. |
||
SOS1 Ligand intermediate-1 |
||
| HY-49514 | Get quote | Ask for price |
|
Description: VHL Ligand intermediate-1 (intermediate 18a) is an intermediate in the synthesis of VHL E3 ubiquitin ligase ligand and can be used to synthesize PROTACs[1]. |
||
SOS1 Ligand intermediate-2 |
||
| HY-49515 | Get quote | Ask for price |
|
Description: VHL Ligand intermediate-2 (compound 18c) is an intermediate for the synthesis of VHL E3 ubiquitin ligase ligand and can be used to synthesize PROTACs[1]. |
||
Pethidine Intermediate A |
||
| M339095 | 5g | EUR 1200 |
|
Description: 3627-62-1 |
||
Pethidine Intermediate C |
||
| P292503 | 10mg | EUR 397 |
|
Description: 3627-48-3 |
||
SPT16 (Intermediate Domain) |
||
| MBS395740-01mg | 0.1mg | EUR 425 |
SPT16 (Intermediate Domain) |
||
| MBS395740-5x01mg | 5x0.1mg | EUR 1760 |
Tubulysin A intermediate-1 |
||
| HY-400684 | Get quote | Ask for price |
|
Description: Tubulysin A intermediate-1 is an intermediate in the synthesis of the cytotoxic peptide Tubulysin A (HY-15995). Tubulysin A (TubA) is an antibiotic, anti-microtubule toxins, and apoptosis inducer isolated from myxobacteria. Tubulysin A has anti-angiogenic, anti-microtubule, anti-mitotic, and anti-proliferative activities. Tubulysin A arrests cells in the G2/M phase, effectively inhibits tubulin polymerization, and induces depolymerization of detached microtubules. Tubulysin A acts as an ADC cytotoxin (ADC Cytotoxin) to synthesize ADC[1]. |
||
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (PE) |
||
| MBS6157481-01mL | 0.1(mL | EUR 875 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (PE) |
||
| MBS6157481-5x01mL | 5x0.1mL | EUR 3800 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (PE) |
||
| MBS6157482-01mL | 0.1(mL | EUR 875 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (PE) |
||
| MBS6157482-5x01mL | 5x0.1mL | EUR 3800 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (AP) |
||
| MBS6130966-01mL | 0.1(mL | EUR 875 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (AP) |
||
| MBS6130966-5x01mL | 5x0.1mL | EUR 3800 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (AP) |
||
| MBS6130967-01mL | 0.1(mL | EUR 875 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (AP) |
||
| MBS6130967-5x01mL | 5x0.1mL | EUR 3800 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (AP) |
||
| MBS6376392-01mL | 0.1mL | EUR 920 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (AP) |
||
| MBS6376392-5x01mL | 5x0.1mL | EUR 3990 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (PE) |
||
| MBS6376402-01mL | 0.1mL | EUR 920 |
DNAI1 (Dynein Intermediate Chain 1, Axonemal, Axonemal Dynein Intermediate Chain 1) (PE) |
||
| MBS6376402-5x01mL | 5x0.1mL | EUR 3990 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (AP) |
||
| MBS6376403-01mL | 0.1mL | EUR 920 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (AP) |
||
| MBS6376403-5x01mL | 5x0.1mL | EUR 3990 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (PE) |
||
| MBS6376413-01mL | 0.1mL | EUR 920 |
DNAI2 (Dynein Intermediate Chain 2, Axonemal, Axonemal Dynein Intermediate Chain 2) (PE) |
||
| MBS6376413-5x01mL | 5x0.1mL | EUR 3990 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (AP) |
||
| MBS6286184-02mL | 0.2mL | EUR 980 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (AP) |
||
| MBS6286184-5x02mL | 5x0.2mL | EUR 4250 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (APC) |
||
| MBS6286185-02mL | 0.2mL | EUR 980 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (APC) |
||
| MBS6286185-5x02mL | 5x0.2mL | EUR 4250 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (FITC) |
||
| MBS6286187-02mL | 0.2mL | EUR 980 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (FITC) |
||
| MBS6286187-5x02mL | 5x0.2mL | EUR 4250 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (PE) |
||
| MBS6286194-02mL | 0.2mL | EUR 980 |
CILP2, ID (CILP2, Cartilage intermediate layer protein 2, Cartilage intermediate layer protein 2 C1, Cartilage intermediate layer protein 2 C2) (PE) |
||
| MBS6286194-5x02mL | 5x0.2mL | EUR 4250 |
Intermediate of Pregabalin |
||
| MBS3602784-100mg | 100mg | EUR 215 |
Intermediate of Pregabalin |
||
| MBS3602784-200mg | 200mg | EUR 255 |
Intermediate of Pregabalin |
||
| MBS3602784-50mg | 50mg | EUR 200 |
Intermediate of Pregabalin |
||
| MBS3602784-5x200mg | 5x200mg | EUR 835 |
Intermediate of Pregabalin |
||
| MBS575218-100mg | 100mg | EUR 155 |
Intermediate of Pregabalin |
||
| MBS575218-10mg | 10mg | EUR 130 |
Intermediate of Pregabalin |
||
| MBS575218-200mg | 200mg | EUR 190 |
Intermediate of Pregabalin |
||
| MBS575218-50mg | 50mg | EUR 145 |
Intermediate of Pregabalin |
||
| MBS575218-5mg | 5mg | EUR 120 |
Intermediate of Pregabalin |
||
| T0531-10mg | 10mg | Ask for price |
|
Description: Intermediate of Pregabalin |
||
Intermediate of Pregabalin |
||
| T0531-1g | 1g | Ask for price |
|
Description: Intermediate of Pregabalin |
||
Intermediate of Pregabalin |
||
| T0531-1mg | 1mg | Ask for price |
|
Description: Intermediate of Pregabalin |
||